Cite
HARVARD Citation
Jurczak, W. et al. (2018). Phase IIa study of the CD19 antibody MOR208 in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma. Annals of oncology. pp. 1266-1272. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Jurczak, W. et al. (2018). Phase IIa study of the CD19 antibody MOR208 in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma. Annals of oncology. pp. 1266-1272. [Online].